Caraco Pharmaceutical (CPD) Granted Tentative FDA Approval for Generic Zyrtec
More News related to CPD
- FDA Raid On Caraco Causes Shareholder Investigation by Kendall Law Group
- Caraco Pharma (CPD) Provides Update Following FDA Action
- Caraco Pharmaceutical Laboratories, Ltd. Updates on Financial Position
- Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Action
- Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Caraco Pharmaceutical Laboratories, Ltd.
Caraco Pharmaceutical Laboratories, Ltd., (Amex: CPD) said the FDA has granted tentative approval for the Company's Abbreviated New Drug Application for Cetirizine Hydrochloride Chewable Tablets, 5 mg and 10 mg. Final approval to market this product is anticipated subsequent to the expiry of patent protection on December 25, 2007.
Related Categories
FDAStocks Mentioned
+25.45Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
